| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |